Dr. Joe LaTorre is a clinical researcher and Harvard Divinity School lecturer with over seven years of experience specializing in psychedelic therapeutics, academic instruction, and clinical trial design. He currently serves as a doctoral-level clinician and unblinded psychological rater for Phase 3 psilocybin and LSD clinical trials at Adams Clinical in Boston, following his previous role spearheading FDA-approved Phase 2 trials at the University of Washington School of Medicine.